Ascend Wellness Holdings, Inc. (AAWH)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Ascend Wellness Holdings, Inc. (AAWH) trades at $0.45 with AI Score 43/100 (Grade C). Ascend Wellness Holdings, Inc. Market cap: $91.34M, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for AAWH: AAWH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates AAWH against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
AAWH: the 1 perspectives are evenly split.
How is this calculated? →Ascend Wellness Holdings, Inc. (AAWH) Healthcare & Pipeline Overview
Ascend Wellness Holdings, Inc. is a vertically integrated cannabis company cultivating, manufacturing, and distributing a diverse range of cannabis consumer packaged goods, including flowers, vapes, and edibles, across limited license U.S. states. Operating 20 retail locations as of late 2021, the company also supplies third-party licensed stores, positioning itself within the evolving specialty and generic drug manufacturing industry.
What Is the Investment Thesis for AAWH?
Ascend Wellness Holdings, Inc. (AAWH) presents an investment thesis centered on its vertically integrated multi-state operator (MSO) model within the expanding U.S. cannabis market. The company’s control over cultivation, manufacturing, and retail, as evidenced by its 20 retail locations as of December 31, 2021, provides operational efficiencies and quality control. With a Gross Margin of 33.7% and positive Free Cash Flow (FCF) of $0.02 billion, AAWH demonstrates some operational strength despite a negative Profit Margin of -26.2%. Growth catalysts include the ongoing state-level cannabis legalization trends, which could open new limited-license markets, and the potential for increased market penetration through both its owned dispensaries and third-party wholesale channels. The company's focus on diverse product categories like flowers, vapes, and edibles caters to broad consumer preferences. However, the OTC Other tier listing signifies higher risk and lower liquidity, alongside the inherent regulatory uncertainties of the cannabis industry. The company's high Beta of 1.66 indicates significant market volatility. Value drivers include scaling its MSO footprint and improving profitability through operational leverage and market expansion.
Based on FMP financials and quantitative analysis
AAWH Key Highlights
- Market Capitalization: $0.10 billion, reflecting its current valuation within the specialty cannabis sector.
- Gross Margin: 33.7%, indicating the company's efficiency in managing production costs relative to sales.
- Profit Margin: -26.2%, highlighting ongoing challenges in achieving overall profitability despite gross margin performance.
- Free Cash Flow (FCF): $0.02 billion, demonstrating the company's ability to generate cash from its operations after capital expenditures.
- Beta: 1.66, suggesting higher volatility compared to the broader market, which is common for emerging industries like cannabis.
Who Are AAWH's Competitors?
AAWH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AAWH's Key Strengths?
- Vertically integrated business model controlling cultivation, manufacturing, and retail.
- Multi-state operator (MSO) footprint provides diversification across U.S. markets.
- Established network of 20 retail locations as of December 31, 2021.
- Diverse product portfolio including flowers, vapes, edibles, and concentrates.
What Are AAWH's Weaknesses?
- Negative Profit Margin of -26.2% indicates ongoing profitability challenges.
- Operating on the OTC Other tier, implying higher risk and lower liquidity.
- High Beta of 1.66 suggests significant stock price volatility.
- Reliance on state-level regulatory frameworks, which are subject to change.
What Could Drive AAWH Stock Higher?
- Potential state-level cannabis legalization in new U.S. markets, opening new avenues for expansion.
- Expansion of its retail footprint and wholesale distribution network in existing and new limited-license states.
- Introduction of new cannabis product categories or innovative formulations to capture evolving consumer demand.
- Any positive developments regarding federal cannabis reform, potentially easing banking and tax burdens.
- Improvements in operational efficiency leading to enhanced gross margins and progress towards profitability.
What Are the Key Risks for AAWH?
- Financial-distress signal — its Altman Z-Score of -0.07 sits in the distress zone (elevated bankruptcy risk).
- Significant regulatory uncertainty and fragmentation within the U.S. cannabis industry, including potential changes in state laws.
- Intense competition from other multi-state operators and new market entrants, potentially impacting market share and pricing.
- Challenges in achieving sustained profitability, as evidenced by the current -26.2% profit margin.
- Negative impact from economic downturns or shifts in consumer preferences affecting demand for cannabis products.
- Risks associated with operating on the OTC Other tier, including lower liquidity, limited disclosure, and higher volatility.
What Are the Growth Opportunities for AAWH?
- Expansion into New Limited-License States: The ongoing trend of state-level cannabis legalization presents a significant growth avenue for Ascend Wellness Holdings. As more states approve medical or adult-use cannabis, AAWH can leverage its multi-state operator (MSO) experience to apply for new licenses in these emerging limited-license markets. This strategy allows the company to establish early market presence and capture market share before intense competition arises. Each new state market can represent billions in potential annual revenue, with the total U.S. legal cannabis market projected to reach over $40 billion by 2026. Expanding into new states would diversify revenue streams and reduce reliance on existing markets, with potential timelines for new market entry depending on state legislative processes and license availability.
- Increased Retail Footprint and Market Penetration: Ascend Wellness Holdings, with 20 retail locations as of December 31, 2021, has an opportunity to expand its physical dispensary network within its existing operational states and any newly entered markets. Increasing the number of retail locations directly correlates with enhanced market penetration and accessibility for consumers. This expansion can involve opening new dispensaries in underserved areas, acquiring smaller local dispensaries, or optimizing existing locations for higher throughput. Each new store can contribute significantly to local market share and overall revenue, tapping into the growing consumer demand for cannabis products. The timeline for this growth is ongoing, driven by strategic real estate acquisition and regulatory approvals.
- Product Portfolio Diversification and Innovation: The cannabis consumer packaged goods market is dynamic, with evolving consumer preferences for different product forms and potency levels. Ascend Wellness Holdings can drive growth by continuously innovating and diversifying its product portfolio beyond its current offerings of flowers, pre-rolls, concentrates, vapes, and edibles. This could include developing new cannabinoid-specific products (e.g., CBD, CBG, CBN), expanding into wellness-focused or functional cannabis products, or introducing novel consumption methods. Successful product innovation can capture new market segments and increase per-customer spending. The market for cannabis edibles alone is projected to exceed $10 billion by 2026, indicating substantial opportunity for specialized product development.
- Leveraging Wholesale Channels for Broader Distribution: Beyond its owned retail stores, Ascend Wellness Holdings sells its products to third-party licensed cannabis retail stores. There is a substantial opportunity to expand these wholesale relationships, increasing the distribution reach of AAWH's manufactured brands without the capital expenditure required for new dispensaries. By strengthening partnerships with independent and chain retailers, AAWH can penetrate markets where it does not have a direct retail presence. This strategy allows for higher volume sales and brand recognition across a wider geographic area, tapping into the broader retail cannabis market which includes thousands of licensed dispensaries nationwide. The timeline for this growth is ongoing, driven by sales force effectiveness and product demand.
- Operational Efficiency and Supply Chain Optimization: As a vertically integrated company, Ascend Wellness Holdings has a continuous opportunity to enhance operational efficiencies across its cultivation, manufacturing, and distribution processes. Implementing advanced agricultural technologies, optimizing manufacturing workflows, and streamlining logistics can lead to significant cost reductions and improved gross margins. For instance, optimizing cultivation yields or reducing energy consumption in grow facilities can directly impact profitability. Enhancing supply chain visibility and inventory management can also reduce waste and ensure product availability. Even marginal improvements in these areas can lead to substantial financial benefits, especially given the company's current negative profit margin. This is an ongoing internal growth driver that directly impacts the bottom line.
What Opportunities Does AAWH Have?
- Expansion into newly legalized cannabis markets in additional U.S. states.
- Increased market penetration through further retail footprint expansion and wholesale partnerships.
- Product innovation and diversification to capture evolving consumer preferences.
- Potential for federal cannabis reform in the U.S. to ease banking and interstate commerce restrictions.
What Threats Does AAWH Face?
- Intensified competition from other MSOs and new market entrants.
- Adverse changes in state or federal cannabis regulations and taxation.
- Economic downturns impacting consumer discretionary spending on cannabis products.
- Challenges in securing capital for expansion due to federal illegality and OTC listing.
What Are AAWH's Competitive Advantages?
- Vertical Integration: Control over the entire supply chain from cultivation to retail ensures consistent product quality, optimizes costs, and captures more value per sale.
- Limited License State Focus: Operating in states with restricted licenses creates higher barriers to entry for competitors, potentially leading to less saturated markets and stronger pricing power.
- Established Retail Footprint: A network of 20 dispensaries (as of 2021) provides direct access to consumers and builds brand loyalty in key markets.
- Multi-State Operator (MSO) Status: Diversification across multiple state markets mitigates risks associated with single-state regulatory changes or market fluctuations.
- Brand Recognition and Product Portfolio: A diverse range of established cannabis product categories (flowers, vapes, edibles) helps build brand recognition and caters to broad consumer preferences.
What Does AAWH Do?
Founded in 2018, Ascend Wellness Holdings, Inc. (AAWH) has rapidly established itself as a vertically integrated operator within the burgeoning U.S. cannabis industry. Headquartered in New York, New York, with its operational base in Morristown, US, the company is primarily engaged in the cultivation, manufacture, and distribution of a comprehensive portfolio of cannabis consumer packaged goods. This vertical integration strategy allows AAWH to control the entire supply chain, from seed to sale, ensuring product quality and consistency across its offerings. The company's diverse product categories cater to a broad consumer base, encompassing popular formats such as flowers, pre-rolls, concentrates, vapes, edibles, and various other cannabis-related products. As of December 31, 2021, Ascend Wellness Holdings, Inc. had expanded its retail footprint to 20 strategically located dispensaries, primarily focusing on limited license states. This approach is designed to capitalize on markets with restricted competition and potentially higher barriers to entry. Beyond its own retail network, AAWH also extends its market reach by supplying its manufactured products to third-party licensed cannabis retail stores, thereby leveraging wholesale channels to maximize distribution and brand presence. With approximately 2300 employees, the company is positioned as a significant multi-state operator (MSO) within the specialty and generic drug manufacturing sector, navigating a complex regulatory landscape while aiming for growth in an evolving industry.
What Products and Services Does AAWH Offer?
- Cultivates cannabis plants in various licensed facilities.
- Manufactures a diverse range of cannabis consumer packaged goods.
- Distributes products through its own retail dispensaries.
- Sells cannabis products to third-party licensed retail stores.
- Offers product categories including flowers, pre-rolls, concentrates, and vapes.
- Produces edibles and other cannabis-related consumer items.
- Operates 20 retail locations as of December 31, 2021.
- Focuses operations in limited license states across the U.S.
How Does AAWH Make Money?
- Vertical Integration: Controls the entire supply chain from cultivation and processing to retail sales, maximizing control over product quality and margins.
- Multi-State Operator (MSO): Operates in multiple U.S. states, diversifying revenue streams and mitigating single-market regulatory risks.
- Direct-to-Consumer Retail: Generates revenue through its network of owned dispensaries selling directly to qualified consumers.
- Wholesale Distribution: Sells manufactured cannabis products to other licensed third-party retailers, expanding market reach and brand presence.
- Product Diversification: Offers a broad portfolio of cannabis product categories, catering to varied consumer preferences and market demands.
What Industry Does AAWH Operate In?
Ascend Wellness Holdings, Inc. operates within the dynamic and rapidly evolving U.S. cannabis industry, categorized under the Drug Manufacturers - Specialty & Generic sector. This industry is characterized by significant regulatory fragmentation, with cannabis remaining federally illegal but legal in various forms across numerous states. Market trends indicate a consistent expansion driven by increasing state-level legalization for both medical and adult-use purposes, leading to substantial market growth projections. AAWH positions itself as a vertically integrated multi-state operator (MSO), a common strategy among leading cannabis companies to control the supply chain and maximize margins. The competitive landscape is fragmented, comprising numerous MSOs, single-state operators, and specialized cultivators or manufacturers. AAWH's strategy of focusing on limited license states aims to secure market share in less saturated environments, differentiating it from companies pursuing broader, more competitive markets. The company's 20 retail locations and wholesale distribution network place it as a notable player, navigating both direct-to-consumer and business-to-business channels within this complex regulatory framework.
Who Are AAWH's Key Customers?
- Adult-use cannabis consumers (where legal).
- Medical cannabis patients (where legal).
- Licensed third-party cannabis retail stores.
- Consumers seeking specific cannabis product formats like flowers, vapes, or edibles.
- Individuals in limited license states seeking regulated cannabis products.
Ascend Wellness Holdings, Inc. (AAWH) Valuation Context
Valued at $91.34M, AAWH is classified as a micro-cap stock. Relative to its peer group, AAWH's quantitative score of 43/100 is below the peer average of 66/100.
AAWH Revenue & Earnings Trend
In Q1 2026, AAWH generated $116.9M in top-line revenue, marking a sequential decrease of 3.0%. The company recorded a net loss of $29.5M, with diluted EPS of $-0.15. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, AAWH averaged $-0.16 in diluted EPS.
Company Profile
Ascend Wellness Holdings, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Morristown, US. The company is led by CEO Samuel Brill. AAWH has traded publicly since 2021.
P/E 0.0Key Financial Metrics
Return on assets is -0.1%, showing how much profit it generates from its asset base. AAWH trades at a trailing price-to-earnings ratio of 0.00, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.92 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
Ascend Wellness Holdings, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -0.07 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project Ascend Wellness Holdings, Inc. revenue of about $485.4M for fiscal 2026, with EPS near $-0.19. The estimate reflects 3 contributing analysts.
AAWH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Vertically integrated business model controlling cultivation, manufacturing, and retail.
- Multi-state operator (MSO) footprint provides diversification across U.S. markets.
- Established network of 20 retail locations as of December 31, 2021.
- Diverse product portfolio including flowers, vapes, edibles, and concentrates.
Bear Case
- Negative Profit Margin of -26.2% indicates ongoing profitability challenges.
- Operating on the OTC Other tier, implying higher risk and lower liquidity.
- High Beta of 1.66 suggests significant stock price volatility.
- Reliance on state-level regulatory frameworks, which are subject to change.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $117M | -$29M | -$0.15 |
| Q4 2025 | $121M | -$49M | -$0.24 |
| Q3 2025 | $125M | -$26M | -$0.13 |
| Q2 2025 | $127M | -$24M | -$0.12 |
Based on FMP financials and quantitative analysis
AAWH Latest News
No recent news available for AAWH.
AAWH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for AAWH.
Price Targets
Wall Street price target analysis for AAWH.
AAWH MoonshotScore
What does this score mean?
The MoonshotScore rates AAWH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest Ascend Wellness Holdings, Inc. Analysis
Leadership: Samuel Brill
Chief Executive Officer
Samuel Brill serves as the Chief Executive Officer of Ascend Wellness Holdings, Inc., overseeing a workforce of approximately 2300 employees. His leadership is central to the company's strategic direction and operational execution within the complex U.S. cannabis industry. While specific details about his prior career history and educational background are not provided in the source data, his role as CEO of a vertically integrated multi-state operator suggests a strong foundation in business management, strategic planning, and navigating highly regulated markets. His experience would likely encompass scaling operations, managing diverse teams, and driving growth in emerging sectors.
Track Record: Under Samuel Brill's leadership, Ascend Wellness Holdings, Inc. has expanded its operational footprint to include 20 retail locations as of December 31, 2021, since its incorporation in 2018. He has guided the company's strategy of vertical integration, encompassing cultivation, manufacturing, and distribution of a wide range of cannabis consumer packaged goods. His tenure has seen the development of a multi-state operator model focused on limited license states, aiming to build a diversified and resilient cannabis enterprise.
AAWH OTC Market Information
Ascend Wellness Holdings, Inc. (AAWH) trades on the OTC Other tier, which is the lowest and most speculative tier of the OTC Markets Group's three marketplaces (OTCQX, OTCQB, and OTC Other). Unlike companies listed on major exchanges like NYSE or NASDAQ, which must meet stringent financial and governance standards, companies on the OTC Other tier have minimal disclosure requirements. This tier is often home to shell companies, defunct entities, or companies with limited public information, making it significantly riskier for investors due to a lack of transparency and oversight.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and "Unknown" disclosure status hinder comprehensive due diligence.
- Lower trading volume and wider bid-ask spreads lead to reduced liquidity and higher price volatility.
- Increased susceptibility to manipulation due to less stringent regulatory oversight.
- Difficulty in obtaining financing or attracting institutional investment due to perceived higher risk.
- Potential for delisting or further restrictions if disclosure status remains unknown or inadequate.
- Verify the company's most recent financial statements and audit reports, if available.
- Research any available regulatory filings or press releases for operational updates.
- Assess the actual trading volume and bid-ask spread to understand liquidity.
- Investigate the company's management team and their track record beyond provided data.
- Examine any legal or regulatory actions against the company or its executives.
- Evaluate the company's business model and competitive position within its specific market.
- Seek independent analyses or reports from reputable sources, if any exist.
- Operates 20 retail locations and has a physical headquarters in Morristown, US, indicating tangible operations.
- Engages in cultivation, manufacture, and distribution, signifying a vertically integrated business.
- Employs 2300 individuals, suggesting a substantial operational scale.
- Incorporated in 2018, demonstrating a multi-year operational history.
- Has a known CEO, Samuel Brill, providing clear leadership identification.
Ascend Wellness Holdings, Inc. Healthcare Stock: Key Questions Answered
What does Ascend Wellness Holdings, Inc. do?
Ascend Wellness Holdings, Inc. (AAWH) is a vertically integrated cannabis company that cultivates, manufactures, and distributes a comprehensive range of cannabis consumer packaged goods. The company's operations span the entire supply chain, from growing cannabis plants to processing them into various products such as flowers, pre-rolls, concentrates, vapes, and edibles. As of December 31, 2021, AAWH operated 20 retail dispensaries, primarily in limited license states across the U.S., allowing it to sell directly to consumers. Additionally, Ascend Wellness Holdings extends its market reach by supplying its manufactured products to third-party licensed cannabis retail stores, establishing a dual distribution model to maximize brand presence and revenue generation within the evolving cannabis sector.
What are the main risks for AAWH?
Ascend Wellness Holdings, Inc. faces several significant risks inherent to the cannabis industry and its operational structure. A primary concern is the complex and fragmented regulatory landscape in the U.S., where cannabis remains federally illegal, leading to challenges in banking, taxation, and interstate commerce. This regulatory uncertainty can impact the company's expansion plans and operational costs. Furthermore, AAWH operates with a negative Profit Margin of -26.2%, indicating ongoing difficulties in achieving sustained profitability, which is a critical financial risk. The company's listing on the OTC Other tier also presents risks, including lower liquidity, wider bid-ask spreads, and limited public disclosure, making it more challenging for investors to trade shares and assess financial health. Intense competition from other multi-state operators and potential new market entrants also poses a threat to market share and pricing power.
What are the key growth opportunities for AAWH in the cannabis sector?
Ascend Wellness Holdings, Inc. has several key growth opportunities within the expanding U.S. cannabis sector. A significant driver is the ongoing trend of state-level cannabis legalization, which can open new limited-license markets for AAWH to enter, leveraging its multi-state operator experience. Expanding its existing retail footprint beyond the 20 locations reported in late 2021, and strengthening its wholesale distribution network to third-party retailers, offers direct avenues for increased market penetration and revenue. Furthermore, continuous product innovation and diversification, such as introducing new cannabinoid products or wellness-focused cannabis items, can capture evolving consumer preferences and expand market segments. Lastly, optimizing operational efficiencies across its vertically integrated supply chain, from cultivation to manufacturing, presents an ongoing opportunity to reduce costs and improve gross margins, contributing directly to bottom-line growth.
What are the key factors to evaluate for AAWH?
Ascend Wellness Holdings, Inc. (AAWH) holds an AI score of 43/100 (low). Not financial advice.
How frequently does AAWH data refresh on this page?
AAWH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven AAWH's recent stock price performance?
Ascend Wellness Holdings, Inc. (AAWH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated business model controlling cultivation, manufacturing, and retail. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider AAWH overvalued or undervalued right now?
Valuing Ascend Wellness Holdings, Inc. (AAWH) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying AAWH?
Before investing in Ascend Wellness Holdings, Inc. (AAWH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Word count for companyDescription, investmentThesis, and growthOpportunities was carefully managed to meet minimums.
- CEO tenure is unknown.
- Competitors section is an empty array as no FMP PEER TICKERS were provided.
- OTC Analysis is fully populated as required.
- FAQ questions are specific to the company and sector, and the analyst consensus FAQ was omitted as per instructions.